Skip to main content
SpringerLink
Log in

Medical Management of Sialorrhea in the Child with Cerebral Palsy

  • Reference work entry
  • First Online:
Cerebral Palsy

  • 92 Accesses

Abstract

Drooling is defined as the inability to control and swallow oral secretions resulting in unintentional loss of saliva from the mouth. This distressing condition chronically afflicts many patients with cerebral palsy and has numerous deleterious effects such as skin irritation, perioral infection, aspiration pneumonia, soiled clothing, assistive equipment damage, increased caregiver burden, lowered self-esteem, social isolation, and an overall lower quality of life. Clinical assessment and quantification of drooling are important for planning and monitoring the effectiveness of interventions. Common assessment scales include the Drooling Quotient, the Drooling Severity and Frequency Scale, and the Drooling Impact Scale. Treatment may initially involve non-pharmacologic, noninvasive methods such as behavioral modifications and oral-motor exercises. Medical therapy typically includes anticholinergic medications, such as glycopyrrolate and scopolamine patches. When conservative therapies are insufficient, direct injection of botulinum toxin into the salivary glands is frequently performed. In patients with more severe drooling that is inadequately managed with other therapies or in patients who desire more permanent solutions, a variety of surgical options are available.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Abbas F, Farid R, Nada I et al (2013) Evaluation of ethanolamine oleate sclerotherapy on the submandibular glands of canines as a potential therapy for sialorrhea. Int J Pediatr Otorhinolaryngol 77(3):351–355. https://doi.org/10.1016/j.ijporl.2012.11.024

    Article  CAS  Google Scholar 

  • Bavikatte G, Sit PL, Hassoon A (2012) Management of drooling of saliva. Br J Med Pract 5(1):a507

    Google Scholar 

  • Blasco P (2002) Management of drooling: 10 years after the Consortium on Drooling, 1990. Dev Med Child Neurol 44:778–781

    Article  Google Scholar 

  • Blasco PA, Allaire JH (1992) Drooling in the developmental disabled: management practices and recommendations. Dev Med Child Neurol 34:849–862. https://doi.org/10.1111/j.1469-8749.1992.tb11382.x

    Article  CAS  Google Scholar 

  • Brodsky L (1993) Drooling in children. In: Arvedson J, Brodsky L (eds) Pediatric swallowing and feeding: assessment and management. Singular Publishing Group, New York, pp 389–416

    Google Scholar 

  • Burch E, Lubeley L, Murakami J (2017) Percutaneous salivary gland ablation using ethanol in a rat model. J Oral Maxil Res 8(4). https://doi.org/10.5037/jomr.2017.8403

  • Bushara KO (1997) Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment – botulinum toxin A injections of the parotid glands. Med Hypotheses 48(4):337–339

    Article  CAS  Google Scholar 

  • Camp-Bruno JA, Winsberg BG, Green-Parsons AR et al (1989) Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 31:309–319

    Article  CAS  Google Scholar 

  • Cardona I, Saint-Martin C, Daniel SJ (2015) Effect of recurrent onabotulinum toxin A injection into the salivary glands: an ultrasound measurement. Laryngoscope 125:E328–E332

    Article  CAS  Google Scholar 

  • Carranza-del Rio J, Clegg NH, Moore A et al (2011) Use of trihexyphenidyl in children with cerebral palsy. Pediatr Neurol 44(3):202–206

    Article  Google Scholar 

  • Dias BLS, Fernandes AR, Maia HSF (2017) Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy. Arq Neuropsiquiatr 75(5):282–287. https://doi.org/10.1590/0004-282X20170033

    Article  Google Scholar 

  • Ekedahl C, Hallén O (1973) Quantitative measurement of drooling. Acta Otolaryngol 75(2–6):464–469. https://doi.org/10.3109/00016487309139776

    Article  CAS  Google Scholar 

  • Fairhurst CBR, Cockerill H (2011) Management of drooling in children. Arch Dis Child Educ Pract Ed 96:25–30

    Article  CAS  Google Scholar 

  • Gold JI, Nicolau CD, Belmont KA et al (2009) Pediatric acupuncture: a review of clinical research. Evid Based Complement Alternat Med 6(4):429–439

    Article  Google Scholar 

  • Heine RG, Catto-Smith AG, Reddihough DS (1996) Effect of antireflux medication on salivary drooling in children with cerebral palsy. Dev Med Child Neurol 38:1030–1036

    Article  CAS  Google Scholar 

  • Hurst D, Cedrone N (2006) Modafinil for drooling in cerebral palsy. J Child Neurol 21(2):112–114

    Article  Google Scholar 

  • Johnson HM, Reid SM, Hazard CJ et al (2004) Effectiveness of the Innsbruck Sensorimotor Activator and Regulator in improving saliva control in children with cerebral palsy. Dev Med Child Neurol 46:39–45

    Article  Google Scholar 

  • Jongerius PH, Rotteveel JJ, Hoogen FVD et al (2001) Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr 160(8):509–512. https://doi.org/10.1007/s004310100784

    Article  CAS  Google Scholar 

  • Jongerius PH, van Tiel P, van Limbeek J et al (2003) A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Arch Dis Child 88:911–914

    Article  CAS  Google Scholar 

  • Khan WU, Campisi P, Nadarajah S et al (2011) Botulinum toxin A for treatment of sialorrhea in children. Arch Otolaryngol 137(4):339. https://doi.org/10.1001/archoto.2010.240

    Article  Google Scholar 

  • Koheil R, Sochaniwskyj AE, Bablich K et al (1987) Biofeedback techniques and behavior modification in the conservative remediation of drooling by children with cerebral palsy. Dev Med Child Neurol 29:19–26

    Article  CAS  Google Scholar 

  • Lakraj A, Moghimi N, Jabbari B (2013) Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins 5(5):1010–1031. https://doi.org/10.3390/toxins5051010

    Article  CAS  Google Scholar 

  • Lespargot A, Langevin MF, Muller S et al (1993) Swallowing disturbances associated with drooling in cerebral-palsied children. Dev Med Child Neurol 35:298–304

    Article  CAS  Google Scholar 

  • Lew KM, Younis RT, Lazar RH (1991) The current management of sialorrhea. Ear Nose Throat J 70(2): 99–105

    CAS  Google Scholar 

  • Lewis DW, Fontana C, Mehallick LK et al (1994) Transdermal scopolamine for reduction of drooling in developmentally delayed children. Dev Med Child Neurol 36:484–486

    Article  CAS  Google Scholar 

  • Little SA, Kubba H, Hussain SSM (2009) An evidence-based approach to the child who drools saliva. Clin Otolaryngol 34:236–239

    Article  CAS  Google Scholar 

  • Mato A, Limeres J, Tomas I et al (2010) Management of drooling in disabled patients with scopolamine patches. Br J Clin Pharmacol 69(6):684–688

    Article  Google Scholar 

  • Mier RJ, Bachrach SJ, Lakin RC et al (2000) Treatment of sialorrhoea with glycopyrrolate. Arch Pediatr Adolesc Med 154:1214–1218

    Article  CAS  Google Scholar 

  • Norderyd J, Graf J, Macrusson A et al (2017) Sublingual administration of atropine eyedrops in children with excessive drooling – a pilot study. Int J Paediatr Dent 27:22–29

    Article  Google Scholar 

  • Nunn J (2000) Drooling: review of the literature and proposals for management. J Oral Rehabil 27(9):735–743

    Article  CAS  Google Scholar 

  • Oliveira JB, Evêncio-Neto J, Baratella-Evêncio L (2017) Histological and immunohistochemical findings of the action of botulinum toxin in salivary gland: systematic review. Braz J Biol 77(2):251–259. https://doi.org/10.1590/1519-6984.11115

    Article  CAS  Google Scholar 

  • Paneth N, Hong T, Korzeniewski S (2006) The descriptive epidemiology of cerebral palsy. Clin Perinatol 33(2): 251–267

    Article  Google Scholar 

  • Parkes J, Hill N, Platt MJ (2010) Oromotor dysfunction and communication impairments in children with cerebral palsy: a register study. Dev Med Child Neurol 52:1113–1119

    Article  Google Scholar 

  • Porte MCA, Chaléat-Valayer E, Patte K et al (2014) Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review. Eur J Paediatr Neurol 18(6):649–657. https://doi.org/10.1016/j.ejpn.2014.05.007

    Article  Google Scholar 

  • Proctor GB (2016) The physiology of salivary secretion. Periodontol 70(1):11–25. https://doi.org/10.1111/prd.12116

    Article  Google Scholar 

  • Rapoport A (2010) Sublingual atropine drops for the treatment of pediatric sialorrhea. J Pain Symptom Manag 40(5):783–788

    Article  CAS  Google Scholar 

  • Rashnoo P, Daniel S (2015) Drooling quantification: correlation of different techniques. Int J Pediatr Otorhinolaryngol 79:1201–1205

    Article  Google Scholar 

  • Reddihough D, Erasmus CE, Johnson H et al (2010) Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. Eur J Neurol 17:109–121. https://doi.org/10.1111/j.1468-1331.2010.03131.x

    Article  Google Scholar 

  • Reid SM et al (2005) Third report of the Victorian cerebral palsy register. Department of Child Development and Rehabilitation, Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne

    Google Scholar 

  • Reid SM, Johnson HM, Reddihough DS (2010) The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities. Dev Med Child Neurol 52:e23–e28

    Article  Google Scholar 

  • Rodwell K, Edwards P, Ware RS et al (2012) Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review. Dev Med Child Neurol 54(11):977–987. https://doi.org/10.1111/j.1469-8749.2012.04370.x

    Article  Google Scholar 

  • Rosenbaum P, Paneth N, Leviton A et al (2007) A report: the definition and classification of cerebral palsy. Dev Med Child Neurol 49(6):8–14

    Google Scholar 

  • Senner JE, Logemann J, Zecker S et al (2004) Drooling, saliva production, and swallowing in cerebral palsy. Dev Med Child Neurol 46:801–806

    Article  Google Scholar 

  • Shiels WE (2012) Percutaneous salivary gland ablation for treatment of sialorrhea. Pediatr Radiol 42(Suppl 2):S315–S316

    Google Scholar 

  • Sochaniwskyj A (1982) Drool quantification: noninvasive technique. Arch Phys Med Rehabil 63(12):605–607

    CAS  Google Scholar 

  • Teymoortash A et al (2007) Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells. Br J Pharmacol 152: 161–167

    Article  CAS  Google Scholar 

  • van der Burg JJW, Didden R, Jongerius PH et al (2007) A descriptive analysis of studies on behavioural treatment of drooling (1970–2005). Dev Med Child Neurol 49:390–394

    Article  Google Scholar 

  • van der Burg JJW et al (2008) Behavioural treatment of drooling: a methodological critique of the literature with clinical guidelines and suggestions for future research. In: Drooling in children with cerebral palsy: impact and behavioural treatment. CIP-Data Koninlkijke Bibiotheek, Den Haag, pp 67–89

    Google Scholar 

  • van Hulst K, Lindeboom R, van der Burg J et al (2012) Accurate assessment of drooling severity with the 5-minute drooling quotient in children with developmental disabilities. Dev Med Child Neurol 54: 1121–1126

    Article  Google Scholar 

  • Walshe M, Smith M, Pennington L. Interventions for drooling in children with cerebral palsy. Cochrane Database of Systematic Reviews, July 2010. https://doi.org/10.1002/14651858.cd008624

  • Wong V, Sun JG, Wong W (2001) Traditional Chinese medicine (tongue acupuncture) in children with drooling problems. Pediatr Neurol 25(1):47–54

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Radiology, Department of Medical Imaging, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA

    Jeremiah Sabado

  2. Nemours/AI duPont Hospital for Children, Wilmington, DE, USA

    Laura Owens

  3. Thomas Jefferson University, Philadelphia, PA, USA

    Laura Owens

Authors
  1. Jeremiah Sabado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Owens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeremiah Sabado .

Editor information

Editors and Affiliations

  1. Department of Orthopaedics, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA

    Freeman Miller

  2. Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Wilmington, USA

    Steven Bachrach

  3. Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA

    Nancy Lennon

  4. Columbia University, Irving Medical Center, Programs in Physical Therapy, New York, NY, USA

    Margaret E. O'Neil

Section Editor information

  1. AI DuPont Hospital for Children, Wilmington, DE, USA

    Freeman Miller

  2. Department of Pediatrics (Emeritus), Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA

    Steven J. Bachrach

  3. Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA

    Steven J. Bachrach

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Sabado, J., Owens, L. (2020). Medical Management of Sialorrhea in the Child with Cerebral Palsy. In: Miller, F., Bachrach, S., Lennon, N., O'Neil, M.E. (eds) Cerebral Palsy. Springer, Cham. https://doi.org/10.1007/978-3-319-74558-9_61

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74558-9_61

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74557-2

  • Online ISBN: 978-3-319-74558-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation